SCHWARTZ; Jean-Charles

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHWARTZ; Jean-Charles.The latest application filed is for "benzimidazole derivatives as dual histamine h1 and histamine h4 receptor ligands".

Company Profile

5.50.41

SCHWARTZ; Jean-Charles - PARIS FR
Schwartz; Jean-Charles - 75014 Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Benzimidazole Derivatives As Dual Histamine H1 And Histamine H4 Receptor Ligands App 20220281839 - BERREBI-BERTRAND; Isabelle ; et al.	2022-09-08
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands Grant 11,306,069 - Berrebi-Bertrand , et al. April 19, 2	2022-04-19
Novel Combinations Of A H3 Antagonist And A Noradrenaline Reuptake Inhibitor, And The Therapeutical Uses Thereof App 20220079932 - LIGNEAU; Xavier ; et al.	2022-03-17
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof Grant 11,229,632 - Ligneau , et al. January 25, 2	2022-01-25
Therapeutical use of H3-ligands Grant 11,179,329 - Lecomte , et al. November 23, 2	2021-11-23
Tetrahydrate of H3 ligand, its process of preparation and pharmaceutical compositions comprising the same Grant 11,078,183 - Capet , et al. August 3, 2	2021-08-03
Combination of adrenalin with an antidepressant for use in the treatment of shocks Grant 10,952,987 - Schwartz , et al. March 23, 2	2021-03-23
New Therapeutical Use Of H3-ligands App 20200093738 - LECOMTE; Jeanne-Marie ; et al.	2020-03-26
Novel Combinations Of A H3 Antagonist And A Noradrenaline Reuptake Inhibitor, And The Therapeutical Uses Thereof App 20200030310 - LIGNEAU; Xavier ; et al.	2020-01-30
Tetrahydrate Of H3 Ligand, Its Process Of Preparation And Pharmaceutical Compositions Comprising The Same App 20200024256 - CAPET; Marc ; et al.	2020-01-23
Benzimidazole Derivatives As Dual Histamine H1 And Histamine H4 Receptor Ligands App 20190144421 - BERREBI-BERTRAND; Isabelle ; et al.	2019-05-16
Combination Of Adrenalin With An Antidepressant For Use In The Treatment Of Shocks App 20190117614 - SCHWARTZ; Jean-Charles ; et al.	2019-04-25
Form of administration of enkephalinase inhibitor Grant 9,439,853 - Julien , et al. September 13, 2	2016-09-13
Piperidinyl monocarboxylic acids as S1P1 receptor agonists Grant 9,266,867 - Capet , et al. February 23, 2	2016-02-23
6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands Grant 9,255,101 - Berrebi-Bertrand , et al. February 9, 2	2016-02-09
A Combination of Adrenaline with an Antidepressant for Use in the Treatment of Shocks App 20150306065 - SCHWARTZ; Jean-Charles ; et al.	2015-10-29
Benzazole derivatives as histamine H4 receptor ligands Grant 9,029,357 - Berrebi-Bertrand , et al. May 12, 2	2015-05-12
Benzazole Derivatives as Histamine H4 Receptor Ligands App 20150004181 - BERREBI-BERTRAND; Isabelle ; et al.	2015-01-01
Dicarboxylic acid derivatives as S1P1 receptor agonists Grant 8,809,539 - Capet , et al. August 19, 2	2014-08-19
Carbonylated (aza) cyclohexanes as dopamine D.sub.3 receptor ligands Grant 8,802,678 - Capet , et al. August 12, 2	2014-08-12
Benzazole derivatives as histamine H4 receptor ligands Grant 8,802,664 - Berrebi-Bertrand , et al. August 12, 2	2014-08-12
Novel Piperidinyl Monocarboxylic Acids As S1p1 Receptor Agonists App 20140099316 - Capet; Marc ; et al.	2014-04-10
Form of Administration of Enkephalinase Inhibitor App 20130331423 - Julien; Jean-Stephane ; et al.	2013-12-12
Benzazole Derivatives as Histamine H4 Receptor Ligands App 20130231329 - Berrebi-Bertrand; Isabelle ; et al.	2013-09-05
Treatment of Parkinson's disease, obstructive sleep apnea, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H.sub.3-receptor ligands Grant 8,486,947 - Schwartz , et al. July 16, 2	2013-07-16
Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine Grant 8,354,430 - Raga , et al. January 15, 2	2013-01-15
Form of administration of racecadotril Grant 8,318,203 - Schwartz , et al. November 27, 2	2012-11-27
Monohydrochloride Salt Of 1-[3-[3-(4-chlorophenyl) Propoxy]propyl]-piperidine App 20120289546 - RAGA; Manuel ; et al.	2012-11-15
Combinations of an anti emetic agent and an enkephalinase inhibitor Grant 8,222,294 - Schwartz , et al. July 17, 2	2012-07-17
Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine Grant 8,207,197 - Raga , et al. June 26, 2	2012-06-26
Novel Pharmaceutically Acceptable Salts Of 4-(1h-imidazol-4-ylmethyl)pyridine And Their Therapeutical Uses App 20120129892 - Capet; Marc ; et al.	2012-05-24
Combination product comprising an antagonist or inverse agonist of histamine receptor H.sub.3 and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs Grant 8,106,041 - Schwartz , et al. January 31, 2	2012-01-31
Histamine H3-receptor ligands and their therapeutic applications Grant 8,076,329 - Bertrand , et al. December 13, 2	2011-12-13
Non-imidazole Alkylamines As Histamine H3-receptor Ligands And Their Therapeutic Applications App 20110281844 - SCHWARTZ; Jean-Charles ; et al.	2011-11-17
Histamine H.sub.3-receptor ligands and their therapeutic application Grant 8,017,646 - Bertrand , et al. September 13, 2	2011-09-13
Non-imidazole alkylamines as histamine H.sub.3- receptor ligands and their therapeutic applications Grant 7,910,605 - Schwartz , et al. March 22, 2	2011-03-22
Novel Dicarboxylic Acid Derivatives As S1p1 Receptor Agonists App 20100249187 - Capet; Marc ; et al.	2010-09-30
Use Of A Vasopeptidase Inhibitor For The Treatment Of Pulmonary Arterial Hypertension App 20100234393 - Schwartz; Jean-Charles ; et al.	2010-09-16
Very Fast Time Resolved Imaging In Multiparameter Measurement Space App 20090318433 - Schwartz; Jean-Charles ; et al.	2009-12-24
Combination Of Modafinil And An Antagonist Or Inverse Agonist Of The H3 Receptor App 20090312367 - Schwartz; Jean-Charles ; et al.	2009-12-17
Carbonylated (aza) Cyclohexanes As Dopamine D3 Receptor Ligands App 20090286801 - Capet; Marc ; et al.	2009-11-19
Novel Dicarboxylic Acid Derivatives App 20090264469 - Capet; Marc ; et al.	2009-10-22
Form Of Administration Of Racecadotril App 20090186084 - Schwartz; Jean-Charles ; et al.	2009-07-23
Novel Histamine H3-receptor Ligands And Their Therapeutic Applications App 20090111808 - Bertrand; Isabelle ; et al.	2009-04-30
Treatment Of Epilepsy With Non-imidazole Alkylamines Histamine H3-receptor Ligands App 20090082353 - Schwartz; Jean-Charles ; et al.	2009-03-26
Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents Grant 7,432,269 - Capet , et al. October 7, 2	2008-10-07
Monohydrochloride Salt of 1-[3-[3-(4-Chlorophenyl) Propoxy] Propyl] -Piperidine App 20080221162 - Raga; Manuel ; et al.	2008-09-11
Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands App 20080214542 - Capet; Marc ; et al.	2008-09-04
Histamine H3-Receptor Ligands and Their Therapeutic Application App 20080182876 - Bertrand; Isabelle ; et al.	2008-07-31
Novel Arylpiperazine Derivatives App 20080167320 - Capet; Marc ; et al.	2008-07-10
Combinations Of An Anti Emetic Agent And An Enkephalinase Inhibitor App 20070275993 - Schwartz; Jean-Charles ; et al.	2007-11-29
Non-imidazole alkylamines as histamine H.sub.3-receptor ligands and their therapeutic applications Grant 7,169,928 - Schwartz , et al. January 30, 2	2007-01-30
Non-imidazole alkylamines as histamine H.sub.3-receptor ligands and their therapeutic applications Grant 7,138,413 - Schwartz , et al. November 21, 2	2006-11-21
Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications App 20060247223 - Schwartz; Jean-Charles ; et al.	2006-11-02
Combination product comprising an antagonist or inverse agonist of histamine receptor h<sb>3 </sb>and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs App 20060210624 - Schwartz; Jean-Charles ; et al.	2006-09-21
LTA.sub.4 hydrolase inhibitors Grant 7,094,773 - Danvy , et al. August 22, 2	2006-08-22
Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents App 20060089364 - Capet; Marc ; et al.	2006-04-27
Formulation Grant 6,919,093 - Lecomte , et al. July 19, 2	2005-07-19
LTA4 hydrolase inhibitors Grant 6,878,723 - Danvy , et al. April 12, 2	2005-04-12
LTA4 hydrolase inhibitors App 20050027013 - Danvy, Denis ; et al.	2005-02-03
Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids Grant 6,835,851 - Monteil , et al. December 28, 2	2004-12-28
Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications App 20040220225 - Schwartz, Jean-Charles ; et al.	2004-11-04
Polymorphic forms of fasidotril, their methods of preparation and pharmaceutical compositions comprising them Grant 6,767,921 - Capet , et al. July 27, 2	2004-07-27
Polymorphic forms of fasidotril, their methods of preparation and pharmaceutical compositions comprising them App 20030203965 - Capet, Marc ; et al.	2003-10-30
Formulation App 20030166718 - Lecomte, Jeanne-Marie ; et al.	2003-09-04
Tripeptidylpeptidase inhibitors App 20030027743 - Rose, Christiane ; et al.	2003-02-06
Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids App 20020055645 - Monteil, Thierry ; et al.	2002-05-09
Imidazole derivatives as histamine receptor H3 (ANT) agonists Grant 6,248,765 - Schwartz , et al. June 19, 2	2001-06-19
2-naphthamide derivatives and their therapeutic applications Grant 5,985,895 - Wermuth , et al. November 16, 1	1999-11-16
2-Naphthamide derivatives and their therapeutic applications Grant 5,872,119 - Wermuth , et al. February 16, 1	1999-02-16
Imidazole derivatives for pharmaceutical use Grant 5,708,171 - Schwartz , et al. January 13, 1	1998-01-13
Amino acid derivatives, the process for their preparation and their applications to therapy Grant 5,599,951 - Plaquevent , et al. February 4, 1	1997-02-04
Imidazole compounds and their therapeutic applications Grant 5,559,113 - Schwartz , et al. September 24, 1	1996-09-24
4-(4-imidazolyl) piperidines substituted at position 1, their preparation and also their therapeutic applications Grant 5,290,790 - Arrang , et al. March 1, 1	1994-03-01
Process for the preparation of amino acid-derived enatiomeric compounds Grant 5,136,076 - Duhamel , et al. August 4, 1	1992-08-04
Histamine derivative, process for preparing it and its therapeutic use Grant 5,034,539 - Arrang , et al. July 23, 1	1991-07-23
Pharmaceutical compositions and methods for stimulating H.sub.3 histamine receptors Grant 4,767,778 - Arrang , et al. August 30, 1	1988-08-30
Amino acid derivatives and their use as antidepressives and hypotensive agents Grant 4,738,803 - Roques , et al. April 19, 1	1988-04-19
(4-imidazolyl)piperidines, the preparation thereof and their application in therapy Grant 4,707,487 - Arrang , et al. November 17, 1	1987-11-17
Amino acid derivative Grant 4,618,708 - Roques , et al. October 21, 1	1986-10-21
Aminoacid derivatives and their therapeutic applications Grant 4,513,009 - Roques , et al. April 23, 1	1985-04-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.